“Reviewing the Rising Price of EpiPens.”
Meeting Status:
Scheduled
Date:
Location:
Capitol Complex, 2154 RHOB, Washington, DC, 20515, USA
Witnesses
Dr. Douglas Throckmorton
Deputy Director, U.S. Food and Drug Administration, Center for Drug Evaluation and Research,
Ms. Heather Bresch
Chief Executive Officer, Mylan, Inc
Meeting Documents